AA
LLY icon

ALPS Advisors’s Eli Lilly LLY Stock Holding History

ALPS Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.9M Sell
5,330
-237
-4% -$240K 0.02% 249
2025
Q4 		$5.98M Buy
5,567
+320
+6% +$306K 0.03% 227
2025
Q3 		$4M Sell
5,247
-5,212
-50% -$3.88M 0.02% 282
2025
Q2 		$8.15M Sell
10,459
-46
-0.4% -$35.7K 0.05% 184
2025
Q1 		$8.68M Buy
10,505
+169
+2% +$141K 0.05% 171
2024
Q4 		$7.98M Sell
10,336
-32
-0.3% -$26.5K 0.05% 177
2024
Q3 		$9.19M Sell
10,368
-22,953
-69% -$20.6M 0.06% 166
2024
Q2 		$30.2M Hold
33,321
– – 0.21% 54
2024
Q1 		$25.9M Sell
33,321
-100
-0.3% -$71.2K 0.18% 64
2023
Q4 		$19.5M Buy
33,421
+133
+0.4% +$77.6K 0.15% 99
2023
Q3 		$17.9M Buy
33,288
+15,471
+87% +$7.97M 0.15% 105
2023
Q2 		$8.36M Sell
17,817
-437
-2% -$183K 0.07% 149
2023
Q1 		$6.27M Sell
18,254
-986
-5% -$333K 0.06% 163
2022
Q4 		$7.04M Sell
19,240
-996
-5% -$353K 0.06% 167
2022
Q3 		$6.54M Sell
20,236
-41,322
-67% -$13.1M 0.06% 170
2022
Q2 		$20M Buy
+61,558
New +$18.5M 0.19% 103
2022
Q1 		– Sell
-1,576
Closed -$435K – 907
2021
Q4 		$435K Sell
1,576
-15,184
-91% -$3.85M ﹤0.01% 577
2021
Q3 		$3.87M Sell
16,760
-887
-5% -$219K 0.04% 191
2021
Q2 		$4.05M Sell
17,647
-764
-4% -$153K 0.04% 187
2021
Q1 		$3.44M Sell
18,411
-2,798
-13% -$547K 0.03% 198
2020
Q4 		$3.58M Sell
21,209
-1,489
-7% -$222K 0.04% 198
2020
Q3 		$3.36M Sell
22,698
-1,767
-7% -$273K 0.05% 184
2020
Q2 		$4.02M Buy
24,465
+2,946
+14% +$452K 0.05% 171
2020
Q1 		$2.98M Buy
21,519
+410
+2% +$56.3K 0.05% 183
2019
Q4 		$2.77M Sell
21,109
-1,029
-5% -$119K 0.02% 203
2019
Q3 		$2.48M Sell
22,138
-10,377
-32% -$1.16M 0.02% 196
2019
Q2 		$3.6M Buy
32,515
+1,035
+3% +$122K 0.03% 174
2019
Q1 		$4.08M Sell
31,480
-6,427
-17% -$782K 0.03% 180
2018
Q4 		$4.39M Sell
37,907
-446,632
-92% -$49.9M 0.03% 162
2018
Q3 		$52M Sell
484,539
-88,646
-15% -$8.86M 0.34% 47
2018
Q2 		$48.9M Sell
573,185
-38,074
-6% -$3.13M 0.32% 58
2018
Q1 		$47.3M Buy
+611,259
New +$49.2M 0.38% 56
2017
Q4 		– Sell
-547,248
Closed -$46.8M – 864
2017
Q3 		$46.8M Sell
547,248
-30,850
-5% -$2.53M 0.33% 60
2017
Q2 		$47.6M Buy
578,098
+19,110
+3% +$1.56M 0.33% 49
2017
Q1 		$47M Buy
558,988
+779
+0.1% +$62.4K 0.32% 57
2016
Q4 		$41.1M Buy
+558,209
New +$41.6M 0.3% 33
2015
Q4 		– Sell
-245,173
Closed -$205K – 697
2015
Q3 		$205K Sell
245,173
-52,237
-18% -$4.41M 0.22% 48
2015
Q2 		$24.8M Sell
297,410
-40,712
-12% -$3.1M 0.21% 51
2015
Q1 		$24.6M Buy
338,122
+38,070
+13% +$2.71M 0.2% 45
2014
Q4 		$20.7M Buy
300,052
+37,656
+14% +$2.54M 0.16% 77
2014
Q3 		$17M Buy
262,396
+4,649
+2% +$294K 0.13% 63
2014
Q2 		$16M Buy
257,747
+59,481
+30% +$3.55M 0.14% 41
2014
Q1 		$11.7M Sell
198,266
-11,840
-6% -$661K 0.11% 70
2013
Q4 		$11.3M Buy
210,106
+57,247
+37% +$2.87M 0.11% 49
2013
Q3 		$7.69M Buy
152,859
+44,367
+41% +$2.32M 0.09% 92
2013
Q2 		$5.33M Buy
+108,492
New +$5.9M 0.07% 86

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ALPS Advisors's LLY Position: Q1 2026 in Review

ALPS Advisors reduced its Eli Lilly (LLY) stake by 4.3% in Q1 2026, selling an estimated $240K and leaving 5,330 shares worth $4.9M. The position accounts for 0.02% of the portfolio, ranked #249.

ALPS Advisors first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $52M in Q3 2018. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ALPS Advisors held 5,330 shares of Eli Lilly worth $4.9M as of Q1 2026.
  • ALPS Advisors sold 237 Eli Lilly shares in Q1 2026, an estimated $240K.
  • Eli Lilly made up 0.02% of ALPS Advisors's portfolio in Q1 2026, its #249 holding.
  • ALPS Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
  • ALPS Advisors's Eli Lilly position peaked at $52M in Q3 2018.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.